Remifentanil and Dexmedetomidine Treat Hypertension: Comment.
No abstract available
References:
Dong R, Li F, Li B, et al.: Effects of an early intensive blood pressure-lowering strategy using remifentanil and dexmedetomidine in patients with spontaneous intracerebral hemorrhage: A multicenter, prospective, superiority, randomized controlled trial. Anesthesiology 2024; 141:100–15
Greenberg SM, Ziai WC, Cordonnier C, et al.; American Heart Association/American Stroke Association: 2022 guideline for the management of patients with spontaneous intracerebral hemorrhage: A guideline from the American Heart Association/American Stroke Association. Stroke 2022; 53:e282–361
Morotti A, Boulouis G, Dowlatshahi D, et al.; International NCCT ICH Study Group: Standards for detecting, interpreting, and reporting noncontrast computed tomographic markers of intracerebral hemorrhage expansion. Ann Neurol 2019; 86:480–92
Abad-Torrent A, Martínez-Vázquez P, Somma J, Hsu YW, Izquierdo E: Remifentanil pharmacodynamics during conscious sedation using algometry: A more clinically relevant pharmacodynamical model. Br J Anaesth 2022; 129:868–78
Weerink MAS, Struys MMRF, Hannivoort LN, Barends CRM, Absalom AR, Colin P: Clinical pharmacokinetics and pharmacodynamics of dexmedetomidine. Clin Pharmacokinet 2017; 56:893–913